Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Biolistic Particle Delivery System Market size was over USD 22.42 billion in 2024 and is projected to reach USD 98.97 billion by 2037, witnessing around 12.1% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of biolistic particle delivery system is assessed at USD 24.73 billion.
The integration of artificial intelligence (AI) is one of the main growth drivers fueling the market. AI integration in Biolistic Particle Delivery Systems can enhance the entire process, from experimental design to execution. AI algorithms can analyze vast datasets, predict optimal parameters for particle delivery, and adapt in real-time to the specific requirements of diverse cell types. This intelligent automation can significantly reduce the time and resources traditionally required for system optimization and experimental setup. A study published demonstrated a 20% improvement in gene delivery efficiency when AI algorithms were employed to optimize particle velocity and penetration depth in a Biolistic system.
Biolistic particle delivery systems, also known as gene guns, are devices used in genetic engineering and biotechnology to introduce foreign genes into target cells. They are commonly used in plant transformation and have applications in genetic research and biopharmaceutical development. Supportive regulatory environments that facilitate the development and commercialization of genetic engineering technologies can positively impact the growth of the market.
